| 摘要 |
FIELD: medicine, biochemistry. ^ SUBSTANCE: invention relates to the development of a method for inhibition of inflammation by providing cell with monoterpene compositions that inhibit activity of factor NF-kB. These compositions can comprise also a moiety as a carrier that provides membrane-permeable properties for monoterpene composition. A carrier can comprise triterpenoid moieties, sugars, lipids or even additional monoterpenoid moieties. Composition can comprise additional chemical functional agents. Invention provides enhancing effectiveness in treatment of inflammatory states, in particular, precancer states. ^ EFFECT: valuable medicinal properties of compositions. ^ 54 cl, 55 tbl, 62 dwg, 48 ex |
